This message was sent to ##Email## January 4, 2017     Home  |   About   Subscribe  |   Archive  |   Advertise   Experimental brain cancer treatment is a success Time Using the immune system to beat cancer is quickly becoming a promising new strategy for battling tumors. But most of the success so far has been with blood cancers like lymphomas and leukemias. Immunotherapy, as it’s called, has yet to prove itself with solid tumors like breast, prostate, lung, colon and brain cancers. But in a report published in the New England Journal of Medicine, researchers led by Dr. Behnam Badie from the City of Hope Beckman Research Institute and Medical Center say that the same immune-based therapy that is successful against blood cancers also helped a patient with advanced brain cancer.  READ MORE    SPONSORED CONTENT Promoted by CHAMPS Oncology Learn How i2o® Can Transform Your Cancer Data into Actionable Information insight2oncology® Offers New Perspective of Your Current Market Position Migration Cancer Analytics Reveal Valuable Patient Information i2o® Highlights Most Valuable Information to Cancer Center Administrators Contact Us to Schedule Your insight2oncology® Demo CHAMPS insight2oncology® and i2o® Receive Registered Trademark   Cancer programs to hold annual conference September 2017 Plan now to attend the 2017 Cancer Programs Annual Conference, Sept. 7-9 in Chicago. The conference will cover content from all areas of the American College of Surgeons Cancer Programs - American Joint Committee on Cancer, the Clinical Research Program, Commission on Cancer, National Accreditation Program for Breast Centers and the National Cancer Database. Further details on this event will be available soon. Click here to be added to the mailing list for the annual conference. (Please note: The 2017 Cancer Programs Annual Conference replaces the educational event traditionally held in June.) READ MORE Vaccine shows promising results for early-stage breast cancer patients ScienceDaily Immunotherapy is a fast-growing area of cancer research. It involves developing therapies that use a patient's own immune system to fight and kill cancer. Medical researchers are working on a new vaccine that would help early-stage breast cancer patients who have HER2-positive disease.  READ MORE    PRODUCT SHOWCASE Advertisement Wiley's Oncology Apps Enjoy our journals? There’s an app for those! Journals such as those from the American Cancer Society ™, Journal of Surgical Oncology, Cancer Science and more are now available for your iPad and iPhone. Sample issues and abstracts, as well as open articles, can be accessed for free. A subscription to the journal is required to read the full text. Study shows chemo-brain widespread in breast cancer patients UPI Researchers at the University of Rochester's Wilmot Cancer Institute have conducted the largest study to date on the causes of chemo-brain in women with breast cancer. Chemo-brain is the term used to describe cancer-related cognitive impairment such as memory loss, attention problems and difficulty processing information. The condition is prevalent in cancer patients undergoing chemotherapy.  READ MORE Announcing the Commission on Cancer 2016-2017 cancer research paper competition for physicians-in-training CoC The Commission on Cancer is hosting a paper competition for physicians-in-training to foster the importance of oncologic research in support of its mission. Papers are due June 30, 2017.  READ MORE    SPONSORED CONTENT Promoted by InformedDNA FAMMM syndrome may be behind man's multiple cancers Practitioners peddle unneeded genetic tests, supplements Gynecologic oncologists release genetics toolkit for patients, providers InformedDNA CMO is guided by experience as a cancer researcher and survivor Learn how you could be offering genetic counseling to your patients within the next 30 days! Click here to register for our FREE webinar   Social isolation may worsen breast cancer outcomes Chicago Tribune Patients with early breast cancer who are socially isolated have a higher risk of dying from their disease, a new study suggests. Women with fewer social ties to friends, family, community and religious groups, as well as spouses or romantic partners were 43 percent more likely to see their breast cancer return, 64 percent more likely to die from breast cancer and 69 percent more likely to die from any cause, according to a study recently published in the journal Cancer.  READ MORE Obamacare plans don't always include top cancer centers NPR Being told that you have cancer can be scary. Discovering that your health insurance plan doesn't give you access to leading cancer centers may make the diagnosis even more daunting. As insurers in the plans set up under the Affordable Care Act shrink their provider networks and slash the number of plans that offer out-of-network coverage, some consumers are learning that their treatment options can be limited.  READ MORE .  PRODUCT SHOWCASE prIME Patients by prIME Oncology prIME Patients is prIME Oncology’s resource center for patients with cancer and their caregivers. Our patient-focused videos explain, in layman’s terms, how certain treatments fight the various cancers. This information will arm you with the knowledge on what to expect during your course treatment so that you can be an informed part of the decision making team. AJCC Cancer Staging Manual, 8th edition The American Joint Committee on Cancer (AJCC) has released the eighth edition of its Cancer Staging Manual. This edition presents evidence‐based revisions for staging cancer for a number of organ sites and includes the rationale and rules for staging; the definitions of tumor, lymph node involvement and metastasis (TNM); stage groupings; and histologic grade. The new publication can be purchased online at www.cancerstaging.org.     .  SPONSOR SPOTLIGHT     Using immune cells to deliver anti-cancer drugs ScienceDaily Many groups are working to discover new, safer ways to deliver drugs that fight cancer to the tumor without damaging healthy cells. Others are finding ways to boost the body's own immune system to attack cancer cells. For the first time, researchers at Penn State have combined the two approaches by conjugating biodegradable polymer nanoparticles encapsulated with chosen cancer-fighting drugs into immune cells to create a smart, targeted system to attack cancers of specific types.  READ MORE Blogging your way through cancer Cure One of the most difficult aspects of navigating a cancer diagnosis is learning how to manage your time. Cancer is a full-time job. When you add a “cancer to-do list” to your pre-existing “just plain life to-do list,” every minute counts and is accounted for. Whether you tell your inner circle of friends and family or the whole of your social media community, once you’ve shared your diagnosis, the onslaught of messages commences. This outreach is a good thing, as the support of friends and family is critical for someone living with cancer.  READ MORE   The Brief Connect with AJCC Connect with CoC Connect with NAPBC Recent Issues | Subscribe | Unsubscribe | Advertise | Web Version  Colby Horton, Vice President of Publishing, 469-420-2601 | Download media kit Ashley Whipple, Senior Content Editor, 469-420-2642 | Contribute news Disclaimer: The Brief is a digest of news selected for the Commission on Cancer (CoC) and the National Accreditation Program for Breast Centers (NAPBC), both quality programs of the American College of Surgeons, from thousands of sources by the editors of MultiBriefs, an independent organization that also manages and sells advertising. The CoC and NAPBC do not endorse any of the advertised products and services. Opinions expressed in the articles are those of the author and not of the American College of Surgeons, the CoC and the NAPBC. American College of Surgeons 633 N Saint Clair Street | Chicago, IL, 60611-3211  | 800-621-4111 | Contact Us  Learn how to add us to your safe sender list so our emails get to your inbox. 7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063